Dr. Dan Landau receives the 2026 ESMO Award for Translational Research

Written By Catherine Potenski

Awarded for making pioneering contributions that have greatly improved the understanding of cancer evolution, leading to the development of innovative approaches that have advanced the translation of cancer research into clinical applications.

https://www.esmo.org/insights-by-esmo/all-news/a-glucometer-for-cancer-towards-a-scalable-universal-residual-disease-measurement

Catherine Potenski
Next

Dr. Dan Landau Named Inaugural Chair of the Department of Systems and Computational Biomedicine at Weill Cornell Medicine